Paper

Oral fluoropyrimidines in the treatment of colorectal cancer.

Published Sep 1, 1998 · Neal J. Meropol

European journal of cancer

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Oral fluoropyrimidines show potential in maintaining or improving the effectiveness of intravenous 5-FU in colorectal cancer treatment.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Oral fluoropyrimidines in the treatment of colorectal cancer.

References

Citations